☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

ACWY Vax to be discontinued

The manufacturer of ACWY Vax (meningococcal polysaccharide groups ACW135Y vaccine) has written to healthcare professionals advising that this product is being discontinued in the UK. It is expected that stocks will be exhausted by June 2014.

The letter notes that two alternative conjugate vaccines that contain the same A, C, W135 and Y strains are available but also notes that the licensed indications may differ. The brand names for these products are Menveo® and Nimenrix®.

Action: Clinicians who currently use ACWY Vax should be aware of this product being discontinued and make themselves familiar with the alternatives.

Share 'ACWY Vax to be discontinued' by emailShare 'ACWY Vax to be discontinued' on FacebookShare 'ACWY Vax to be discontinued' on TwitterShare 'ACWY Vax to be discontinued' on LinkedInShare 'ACWY Vax to be discontinued' on reddit


One Comment to “ACWY Vax to be discontinued”

  1. […] has already been announced that ACWY Vax is being discontinued this […]

    Pingback by ACWY Vax antibody persistence shorter than expected | Prescribing Advice for GPs — April 26, 2020 #

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.